CLINICAL_TRIALS
trial_result
· 2017-09-15
Clinical Trial Update: An Open-Label Trial of Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of Ramadan [Phase 4]
Summary
Phase 4 open-label trial evaluating dexlansoprazole 60 mg for relief of heartburn during Ramadan; completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: American University of Beirut Medical Center | Conditions: GERD, Proton Pump Inhibitor | Phase 4 | Status: COMPLETED